Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts

24 Mar 2017

Abstract excerpt

// Pontus Eriksson 1 , Gottfrid Sjödahl 2 , Gunilla Chebil 3 , Fredrik Liedberg 2 and Mattias Höglund 1 1 Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden 2 Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden 3 Unilabs, Helsingborg Hospital, Helsingborg, Sweden Correspondence to: Mattias...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Immunotherapy and Biomarkers
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28388586
DOI: 10.18632/oncotarget.16554

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contextsPMID 28388586Read ↗

A Molecular Taxonomy for Urothelial CarcinomaSemantic proximity Read ↗

Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.Semantic proximity Read ↗

Invasiveness of Upper Tract Urothelial Carcinoma: Clinical Significance and Integrative Diagnostic Strategy.Semantic proximity Read ↗

The Emerging Molecular Landscape of Urothelial Carcinoma.Semantic proximity Read ↗

Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.Semantic proximity Read ↗

The Lund Molecular Taxonomy Applied to Non–Muscle-Invasive Urothelial CarcinomaSemantic proximity Read ↗

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort.Semantic proximity Read ↗

HER2 as a target in invasive urothelial carcinoma.Semantic proximity Read ↗

Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.Semantic proximity Read ↗

The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 ExpressionSemantic proximity Read ↗

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.Semantic proximity Read ↗

A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.